Answer
Yes, increased blood glucose levels have been reported with nilotinib, and blood glucose should be assessed before treatment and monitored during treatment.
Sources for this answer
- Tasigna 50mg, 150mg and 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 39Document updated
Sources checked